This report contains market size and forecasts of Low Molecular Weight Heparin Sodium in global, including the following market information:
Global Low Molecular Weight Heparin Sodium Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Low Molecular Weight Heparin Sodium Market Sales, 2017-2022, 2023-2028, (K MT)
Global top five Low Molecular Weight Heparin Sodium companies in 2021 (%)
The global Low Molecular Weight Heparin Sodium market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Enoxaparin Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Low Molecular Weight Heparin Sodium include Aspen, Sanofi-aventis, Pfizer, Opocrin, CSBIO, Dongying Tiandong Pharmaceutica, Changzhou Qianhong Bio-pharma, Techdow and Yantai Dongcheng Pharmaceutical Group. etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Low Molecular Weight Heparin Sodium manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Low Molecular Weight Heparin Sodium Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K MT)
Global Low Molecular Weight Heparin Sodium Market Segment Percentages, by Type, 2021 (%)
Enoxaparin
Dalteparin
Tinzaparin
Fraxiparine
Global Low Molecular Weight Heparin Sodium Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K MT)
Global Low Molecular Weight Heparin Sodium Market Segment Percentages, by Application, 2021 (%)
Medical
Research
Global Low Molecular Weight Heparin Sodium Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K MT)
Global Low Molecular Weight Heparin Sodium Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Low Molecular Weight Heparin Sodium revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Low Molecular Weight Heparin Sodium revenues share in global market, 2021 (%)
Key companies Low Molecular Weight Heparin Sodium sales in global market, 2017-2022 (Estimated), (K MT)
Key companies Low Molecular Weight Heparin Sodium sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Aspen
Sanofi-aventis
Pfizer
Opocrin
CSBIO
Dongying Tiandong Pharmaceutica
Changzhou Qianhong Bio-pharma
Techdow
Yantai Dongcheng Pharmaceutical Group